JB Chemicals & Pharmaceuticals (JBCPL) has launched its new -- Femident Division -- catering to Gynecology and Dental products, in its domestic formulations business. The company has launched this division with over 100 medical representatives and 15 products some of which are first of its kind in its respective segment. The company plans to increase medical representative strength in this division to 300 in upcoming 2 years.

At present, the gynecology and dental segments has combined sales of about Rs 2000 crore with annual robust growth of about 16%. The company would locus both on urban and rural markets, which presents good growth opportunity. The company is already well known among medical fraternity in these segments and launch of this dedicated division will help company strengthen its position in these segments as well as in the domestic market.

The company is focused on domestic market for long term sustainable growth and accordingly plans to exploit other therapeutic segments as well that has good growth potential. The higher penetration into both urban and rural markets with increased field personnel and expansion of the existing products basket including entry into new therapeutic segments are the area the company is focused on and would make necessary investments for growth in this business.

JBCPL is one of India’s leading pharmaceutical companies which manufacture and markets a diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×